Dacoplice 15mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Dacomitinib (15mg)
Overview Dacoplice 15mg Tablet
Oncaspar 15mg tablets are indicated for non-small cell lung carcinoma treatment. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administer Oncaspar 15mg tablets with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, contingent upon your condition and subject to adjustment. Strictly adhere to the prescribed regimen; deviations may result in severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only under your doctor's guidance. Frequently observed side effects include diarrhea, skin rash, mouth sores, nail inflammation, reduced appetite, dry skin, weight loss, hair loss, cough, and itching. Consult your physician immediately if serious side effects such as fatigue, intense itching, jaundice, chest pain or discomfort, or irregular heartbeat develop. Pre- and post-treatment blood tests may be conducted to monitor liver and blood glucose levels. Inform your doctor of all concurrent medications, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception is crucial for both partners during treatment to prevent conception. A patient support program is available in India through Tata 1mg; contact your physician or call 1800-102-1618 for further information.
Uses of Dacoplice 15mg Tablet
Managing Non-small Cell Lung Carcinoma
Major Benefits of Dacoplice 15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Dacoplice 15mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Dacoplice 15mg Tablet:
- Constipation
- Stomatitis (Inflammation of the mouth)
- Rash
- Diarrhea
- Weight loss
- Cough
- Low albumin level in blood
- Paronychia
- Increased glucose level in blood
- Decreased calcium level in blood
- Increased liver enzymes
- Dry skin
- Decreased appetite
- Lymphopenia
How to use Dacoplice 15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dacoplice 15mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Dacoplice 15mg Tablet works:
Dacoplice 15mg tablets target the human epidermal growth factor receptor (HER) protein, a factor potentially accelerating cancer cell proliferation and metastasis. This action can help restrict the cancer's spread.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Dacoplice 15mg Tablet is undetermined; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Dacoplice 15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dacoplice 15mg tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Dacoplice 15mg Tablet's impact on driving ability is undetermined. Refrain from driving should you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate a dosage alteration for Dacoplice 15mg Tablets, which are considered safe for patients with kidney disease.
LiverSAFE IF PRESCRIBED
Patients with liver impairment may safely take Dacoplice 15mg tablets without requiring any alteration to the prescribed dosage.
What if you forget to take Dacoplice 15mg Tablet :
NA
Facts to Know About Dacoplice 15mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently